CVS Health Corp Company Profile (NYSE:CVS)

About CVS Health Corp (NYSE:CVS)

CVS Health Corp logoCVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc. (Omnicare) and Omnicare's long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings. It operates through three segments: Pharmacy Services, Retail/LTC and Corporate. The Pharmacy Services Segment provides a range of pharmacy benefit management (PBM) solutions to its clients. As of December 31, 2016, the Retail/LTC Segment included 9,709 retail locations (of which 7,980 were its stores that operated a pharmacy and 1,674 were its pharmacies located within Target Corporation (Target) stores), its online retail pharmacy Websites,, and, 38 onsite pharmacy stores, its long-term care pharmacy operations and its retail healthcare clinics.

Industry, Sector and Symbol:
  • Sector: Retail/Wholesale
  • Industry: Health Care Plans
  • Sub-Industry: Drug Retail
  • Symbol: NYSE:CVS
  • CUSIP: 12665010
  • Web:
  • Market Cap: $78.08 billion
  • Outstanding Shares: 1,018,795,000
Average Prices:
  • 50 Day Moving Avg: $79.14
  • 200 Day Moving Avg: $78.96
  • 52 Week Range: $69.30 - $98.67
  • Trailing P/E Ratio: 15.98
  • Foreward P/E Ratio: 12.03
  • P/E Growth: 1.64
Sales & Book Value:
  • Annual Revenue: $178.83 billion
  • Price / Sales: 0.44
  • Book Value: $32.95 per share
  • Price / Book: 2.33
  • Annual Dividend: $2.00
  • Dividend Yield: 2.6%
  • EBIDTA: $12.81 billion
  • Net Margins: 3.00%
  • Return on Equity: 17.55%
  • Return on Assets: 6.74%
  • Debt-to-Equity Ratio: 0.70%
  • Current Ratio: 1.18%
  • Quick Ratio: 0.62%
  • Average Volume: 6.46 million shs.
  • Beta: 0.85
  • Short Ratio: 5.58

Frequently Asked Questions for CVS Health Corp (NYSE:CVS)

What is CVS Health Corp's stock symbol?

CVS Health Corp trades on the New York Stock Exchange (NYSE) under the ticker symbol "CVS."

How often does CVS Health Corp pay dividends? What is the dividend yield for CVS Health Corp?

CVS Health Corp declared a quarterly dividend on Thursday, March 2nd. Stockholders of record on Friday, April 21st will be paid a dividend of $0.50 per share on Monday, May 1st. This represents a $2.00 annualized dividend and a dividend yield of 2.61%. The ex-dividend date of this dividend is Wednesday, April 19th. View CVS Health Corp's Dividend History.

How were CVS Health Corp's earnings last quarter?

CVS Health Corp (NYSE:CVS) released its quarterly earnings data on Tuesday, May, 2nd. The company reported $1.17 EPS for the quarter, topping analysts' consensus estimates of $1.10 by $0.07. The firm had revenue of $44.51 billion for the quarter, compared to the consensus estimate of $44.20 billion. CVS Health Corp had a net margin of 3.00% and a return on equity of 17.55%. The company's revenue was up 3.0% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.18 EPS. View CVS Health Corp's Earnings History.

When will CVS Health Corp make its next earnings announcement?

CVS Health Corp is scheduled to release their next quarterly earnings announcement on Monday, July, 31st 2017. View Earnings Estimates for CVS Health Corp.

What guidance has CVS Health Corp issued on next quarter's earnings?

CVS Health Corp issued an update on its FY17 earnings guidance on Tuesday, May, 2nd. The company provided EPS guidance of $5.77-5.93 for the period, compared to the Thomson Reuters consensus EPS estimate of $5.86. CVS Health Corp also updated its Q2 guidance to $1.29-1.33 EPS.

Where is CVS Health Corp's stock going? Where will CVS Health Corp's stock price be in 2017?

17 analysts have issued 1-year price targets for CVS Health Corp's stock. Their forecasts range from $77.00 to $120.00. On average, they anticipate CVS Health Corp's stock price to reach $94.79 in the next twelve months. View Analyst Ratings for CVS Health Corp.

What are analysts saying about CVS Health Corp stock?

Here are some recent quotes from research analysts about CVS Health Corp stock:

  • 1. Guggenheim analysts commented, " Our recent meetings with CEO Larry Merlo, CFO Dave Denton, and VP-IR Nancy Christal further reinforced our confidence in 10% secular growth, which we believe the market is currently undervaluing, at a 13x P/E on somewhat depressed 2017E EPS. Bottom line, even in the face of secular gross margin erosion, in both segments, we believe the company should be able to grow EBIT by 5% on the back of a) natural growth in specialty Rx, b) increasingly rapid product innovation, c) a broadening set of productive relationships, and d) both COGS and SG&A reductions. In our view, this growth merits a valuation closer to a market multiple'we reiterate our Buy rating and $90 PT, implying 15% upside from current levels." (3/28/2017)
  • 2. Evercore ISI analysts commented, "While the quarter proved generally uneventful and guidance was reiterated on the surface (albeit some moving parts below ' dollar profit targets were unchanged in our view ' much of the delta related to where 4Q came out vs mid-point and lower inflation outlook), investors have reacted negatively to the lack of clarity on several key issues with respect to business model risk that in our minds is unlikely to dissipate until later in the year. We think management did an admirable job on the DIR fee issue and a reasonable job on gross to net / rebates, but the reality is that policy noise is unlikely to dissipate and the outlook for 2018 won't start to gain clarity until the summer. We think once we get initial color on the PBM selling season, a better understanding of underlying pharmacy share shifts and profit headwinds and ultimately gain a better picture of 2018 the multiple may start to see some relief. Until then CVS shares remain inexpensive and highly leveraged to tax reform and it appears as if many years of execution are being overshadowed by a tough 18 month stretch. Given how far shares have fallen and in our view strong FCF yield support we retain our Buy rating but acknowledge the path to returns from here is likely most appropriate for those with a multi-year time horizon and a 'deep value' focus." (2/9/2017)
  • 3. According to Zacks Investment Research, "CVS Health posted better-than-expected second-quarter with respected to adjusted EPS. However, revenues missed the Zacks Consensus Estimate. The company’s Pharmacy Services segment continues to benefit from growth in the Specialty Pharmacy business while the Retail Pharmacy segment is gaining from increased same-store sales. We take note of the recently completed Omnicare and Target Pharmacy buyouts which, according to CVS, are strategically perfect fits. CVS Health expects to benefit with multiple opportunities for driving enterprise value from Omnicare and Target in both the near and long term. CVS Health also expects to see market share gain in its specialty pharmacy suite of services with differentiated specialty offerings providing a high level of clinical support to patients. However, the competitive landscape remains tough. The tussle for market share gain in the PBM and retail space also warrants caution." (8/3/2016)

Are investors shorting CVS Health Corp?

CVS Health Corp saw a decline in short interest during the month of April. As of April 28th, there was short interest totalling 24,632,038 shares, a decline of 14.7% from the April 13th total of 28,874,584 shares. Based on an average daily volume of 6,328,688 shares, the days-to-cover ratio is currently 3.9 days. Currently, 2.4% of the company's stock are short sold.

Who are some of CVS Health Corp's key competitors?

Who owns CVS Health Corp stock?

CVS Health Corp's stock is owned by many different of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (7.12%), BlackRock Inc. (6.00%), State Street Corp (4.32%), FMR LLC (2.33%), Bank of America Corp DE (2.20%) and Massachusetts Financial Services Co. MA (1.86%). Company insiders that own CVS Health Corp stock include Andrew Sussman, C David Brown II, David M Denton, Eva C Boratto, Jonathan C Roberts, Larry J Merlo, Lisa Bisaccia, Stephen J Gold and Troyen A Brennan. View Institutional Ownership Trends for CVS Health Corp.

Who sold CVS Health Corp stock? Who is selling CVS Health Corp stock?

CVS Health Corp's stock was sold by a variety of institutional investors in the last quarter, including C WorldWide Group Holding A S, FMR LLC, Wellington Management Group LLP, Janus Capital Management LLC, Ameriprise Financial Inc., Massachusetts Financial Services Co. MA, Caisse DE Depot ET Placement DU Quebec and Alliancebernstein L.P.. Company insiders that have sold CVS Health Corp stock in the last year include Andrew Sussman, David M Denton, Eva C Boratto, Jonathan C Roberts and Troyen A Brennan. View Insider Buying and Selling for CVS Health Corp.

Who bought CVS Health Corp stock? Who is buying CVS Health Corp stock?

CVS Health Corp's stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., LSV Asset Management, Vanguard Group Inc., Schroder Investment Management Group, St. James Investment Company LLC, Morgan Stanley, Swiss National Bank and Edgar Lomax Co. VA. View Insider Buying and Selling for CVS Health Corp.

How do I buy CVS Health Corp stock?

Shares of CVS Health Corp can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of CVS Health Corp stock cost?

One share of CVS Health Corp stock can currently be purchased for approximately $76.64.

Analyst Ratings

Consensus Ratings for CVS Health Corp (NYSE:CVS) (?)
Ratings Breakdown: 6 Hold Ratings, 11 Buy Ratings
Consensus Rating:Buy (Score: 2.65)
Consensus Price Target: $94.79 (23.68% upside)

Analysts' Ratings History for CVS Health Corp (NYSE:CVS)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
5/3/2017Evercore ISIReiterated RatingOutperform$87.00 -> $88.00LowView Rating Details
4/27/2017Tigress FinancialInitiated CoverageBuy -> BuyLowView Rating Details
4/1/2017Jefferies Group LLCSet Price TargetHold$82.00LowView Rating Details
3/28/2017GuggenheimReiterated RatingBuy$90.00LowView Rating Details
3/18/2017Leerink SwannSet Price TargetBuy$90.00LowView Rating Details
2/28/2017Bank of America CorpReiterated RatingBuy$106.67N/AView Rating Details
2/8/2017Deutsche Bank AGReiterated RatingHold$88.00N/AView Rating Details
2/6/2017Atlantic SecuritiesDowngradeOverweight -> Neutral$84.00N/AView Rating Details
2/2/2017Robert W. BairdDowngradeOutperform -> Neutral$86.00 -> $77.00N/AView Rating Details
12/19/2016Credit Suisse Group AGReiterated RatingBuyN/AView Rating Details
12/18/2016Oppenheimer Holdings Inc.Set Price TargetBuy$88.00N/AView Rating Details
11/10/2016ArgusReiterated RatingBuy$120.00 -> $85.00N/AView Rating Details
11/9/2016Barclays PLCReiterated RatingBuy$85.00N/AView Rating Details
11/9/2016MizuhoBoost Price TargetBuy$90.00 -> $111.00N/AView Rating Details
9/12/2016Morgan StanleyReiterated RatingHold$104.00N/AView Rating Details
8/8/2016Citigroup IncLower Price TargetNeutral$115.00 -> $108.00N/AView Rating Details
8/3/2016FBR & CoReiterated RatingOutperform$120.00N/AView Rating Details
5/5/2016MacquarieReiterated RatingOutperform$115.00N/AView Rating Details
5/4/2016Royal Bank of CanadaReiterated RatingOutperform$110.00 -> $115.00N/AView Rating Details
2/10/2016Goldman Sachs Group IncBoost Price TargetNeutral$106.00 -> $110.00N/AView Rating Details
11/3/2015S&P Equity ResearchUpgradeStrong-Buy$121.00N/AView Rating Details
11/2/2015Raymond James Financial, Inc.Boost Price TargetOutperform$105.00 -> $110.00N/AView Rating Details
11/2/2015BMO Capital MarketsBoost Price TargetOutperform$103.00 -> $113.00N/AView Rating Details
11/2/2015JPMorgan Chase & Co.Lower Price TargetOverweight$128.00 -> $123.00N/AView Rating Details
10/21/2015Cowen and CompanyLower Price Target$118.00 -> $113.00N/AView Rating Details
(Data available from 5/27/2015 forward)


Earnings History for CVS Health Corp (NYSE:CVS)
Earnings by Quarter for CVS Health Corp (NYSE:CVS)
Earnings History by Quarter for CVS Health Corp (NYSE:CVS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/2/2017Q1 2017$1.10$1.17$44.20 billion$44.51 billionViewListenView Earnings Details
2/9/2017Q416$1.67$1.71$46.56 billion$46.00 billionViewListenView Earnings Details
11/8/2016Q316$1.57$1.64$45.29 billion$44.60 billionViewListenView Earnings Details
8/2/2016Q216$1.30$1.32$44.28 billion$43.70 billionViewN/AView Earnings Details
5/3/2016Q116$1.16$1.18$43.01 billion$43.20 billionViewN/AView Earnings Details
2/9/2016Q415$1.53$1.53$41.12 billion$41.15 billionViewN/AView Earnings Details
10/30/2015Q315$1.29$1.28$37.81 billion$38.50 billionViewListenView Earnings Details
8/4/2015Q215$1.20$1.22$37.18 billion$37.20 billionViewN/AView Earnings Details
5/1/2015Q115$1.08$1.14$35.93 billion$36.30 billionViewN/AView Earnings Details
2/10/2015Q414$1.21$1.21$36.06 billion$37.06 billionViewN/AView Earnings Details
11/4/2014Q314$1.13$1.15$34.74 billion$35.00 billionViewN/AView Earnings Details
8/5/2014Q214$1.10$1.13$33.47 billion$34.60 billionViewN/AView Earnings Details
5/2/2014Q114$1.05$1.02$32.31 billion$32.70 billionViewN/AView Earnings Details
2/11/2014Q413$1.11$1.12$32.67 million$32.80 millionViewN/AView Earnings Details
11/5/2013Q313$1.02$1.05$31.53 billion$32.00 billionViewListenView Earnings Details
8/6/2013Q2 2013$0.96$0.97$31.13 billion$31.25 billionViewListenView Earnings Details
5/1/2013Q113$0.79$0.83$30.36 billion$30.76 billionViewListenView Earnings Details
2/6/2013Q4 2012$1.10$1.14$31.13 billion$31.40 billionViewListenView Earnings Details
11/6/2012Q312$0.84$0.85$30.09 billion$30.23 billionViewN/AView Earnings Details
8/7/2012$0.80$0.81ViewN/AView Earnings Details
5/2/2012$0.63$0.65ViewN/AView Earnings Details
11/3/2011$0.68$0.70ViewN/AView Earnings Details
8/4/2011$0.65$0.65ViewN/AView Earnings Details
5/5/2011$0.55$0.57ViewN/AView Earnings Details
2/3/2011$0.79$0.80ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for CVS Health Corp (NYSE:CVS)
2017 EPS Consensus Estimate: $5.87
2018 EPS Consensus Estimate: $6.52
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20174$1.09$1.33$1.18
Q2 20174$1.30$1.32$1.31
Q3 20174$1.51$1.64$1.60
Q4 20174$1.71$1.90$1.78
Q1 20183$1.25$1.49$1.35
Q2 20183$1.43$1.62$1.50
Q3 20182$1.73$1.76$1.75
Q4 20182$1.90$1.95$1.93
(Data provided by Zacks Investment Research)


Current Dividend Information for CVS Health Corp (NYSE:CVS)
Most Recent Dividend:5/1/2017
Annual Dividend:$2.00
Dividend Yield:2.61%
Dividend Growth:23.60% (3 Year Average)
Payout Ratio:40.65% (Trailing 12 Months of Earnings)
34.07% (Based on This Year's Estimates)
31.40% (Based on Next Year's Estimates)
Track Record:9 Years of Consecutive Dividend Growth
Dividend Payments by Quarter for CVS Health Corp (NYSE:CVS)

Dividend History by Quarter for CVS Health Corp (NYSE:CVS)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for CVS Health Corp (NYSE:CVS)
Insider Ownership Percentage: 0.58%
Institutional Ownership Percentage: 81.29%
Insider Trades by Quarter for CVS Health Corp (NYSE:CVS)
Institutional Ownership by Quarter for CVS Health Corp (NYSE:CVS)
Insider Trades by Quarter for CVS Health Corp (NYSE:CVS)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/21/2017Troyen A BrennanEVPSell23,849$78.73$1,877,631.77View SEC Filing  
3/17/2017Eva C BorattoEVPSell6,029$79.60$479,908.40View SEC Filing  
3/13/2017Andrew SussmanEVPSell14,104$80.40$1,133,961.60View SEC Filing  
3/10/2017David M DentonCFOSell95,618$80.68$7,714,460.24View SEC Filing  
2/16/2017Jonathan C RobertsEVPSell61,196$80.00$4,895,680.00View SEC Filing  
5/5/2016Larry J MerloCEOSell38,247$105.00$4,015,935.00View SEC Filing  
5/5/2016Troyen A BrennanEVPSell7,517$105.00$789,285.00View SEC Filing  
4/1/2016Stephen J GoldEVPSell21,922$105.00$2,301,810.00View SEC Filing  
3/9/2016Larry J MerloCEOSell38,247$100.00$3,824,700.00View SEC Filing  
2/11/2016Jonathan C. RobertsEVPSell23,355$92.86$2,168,745.30View SEC Filing  
2/1/2016Larry J. MerloCEOSell46,393$96.14$4,460,223.02View SEC Filing  
1/11/2016Larry J. MerloCEOSell46,393$95.00$4,407,335.00View SEC Filing  
10/27/2015Troyen A. BrennanEVPSell23,603$105.00$2,478,315.00View SEC Filing  
7/20/2015Eva C BorattoSVPSell22,107$110.34$2,439,286.38View SEC Filing  
7/15/2015Lisa BisacciaEVPSell49,908$110.00$5,489,880.00View SEC Filing  
6/1/2015C David Brown IIDirectorSell10,000$102.57$1,025,700.00View SEC Filing  
5/1/2015C David Brown IIDirectorSell15,000$100.27$1,504,050.00View SEC Filing  
4/10/2015Andrew SussmanEVPSell17,638$102.38$1,805,778.44View SEC Filing  
4/2/2015Troyen A BrennanEVPSell33,384$102.48$3,421,192.32View SEC Filing  
3/23/2015Troyen A BrennanEVPSell33,274$104.94$3,491,773.56View SEC Filing  
3/20/2015C David Brown IIDirectorSell25,000$104.30$2,607,500.00View SEC Filing  
1/7/2015Jonathan C RobertsEVPSell86,487$95.31$8,243,075.97View SEC Filing  
1/5/2015Larry J MerloCEOSell144,144$94.30$13,592,779.20View SEC Filing  
1/2/2015Andrew SussmanSVPSell4,220$95.67$403,727.40View SEC Filing  
1/2/2015Per Gh LofbergEVPSell347,343$95.28$33,094,841.04View SEC Filing  
11/7/2014Helena FoulkesEVPSell46,325$88.06$4,079,379.50View SEC Filing  
10/27/2014Lisa BisacciaSVPSell33,507$85.00$2,848,095.00View SEC Filing  
9/2/2014Andrew SussmanSVPSell9,020$79.45$716,639.00View SEC Filing  
8/6/2014J. David JoynerEVPSell123,516$76.10$9,399,567.60View SEC Filing  
7/21/2014Eva C BorattoSVPSell22,107$76.77$1,697,154.39View SEC Filing  
7/1/2014David M DentonCFOSell74,989$75.88$5,690,165.32View SEC Filing  
4/2/2014Eva BorattoSVPSell17,108$74.51$1,274,717.08View SEC Filing  
3/31/2014Troyen BrennanEVPSell18,867$74.33$1,402,384.11View SEC Filing  
1/3/2014David DentonCFOSell14,113$70.50$994,966.50View SEC Filing  
1/3/2014Per Gh LofbergEVPSell790,888$70.54$55,789,239.52View SEC Filing  
1/2/2014Jonathan RobertsEVPSell162,192$70.61$11,452,377.12View SEC Filing  
1/2/2014Larry MerloCEOSell228,875$70.76$16,195,195.00View SEC Filing  
12/10/2013Lisa BisacciaSVPSell12,057$68.00$819,876.00View SEC Filing  
11/18/2013Troyen BrennanEVPSell35,387$65.61$2,321,741.07View SEC Filing  
10/18/2013Eva C BorattoSVPSell11,053$60.50$668,706.50View SEC Filing  
10/11/2013Eva BorattoSVPSell11,053$59.50$657,653.50View SEC Filing  
9/13/2013Helena FoulkesEVPSell53,546$60.00$3,212,760.00View SEC Filing  
9/9/2013Helena FoulkesEVPSell47,568$58.65$2,789,863.20View SEC Filing  
9/4/2013Andrew SussmanSVPSell9,020$58.36$526,407.20View SEC Filing  
10/4/2012Andrew SussmanSVPSell9,020$49.00$441,980.00View SEC Filing  
10/1/2012Thomas M MoriartyEVPBuy6,164$48.67$300,001.88View SEC Filing  
9/13/2012David M DentonCFOSell11,526$47.00$541,722.00View SEC Filing  
8/21/2012Jean Pierre MillonDirectorSell33,726$45.73$1,542,289.98View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for CVS Health Corp (NYSE:CVS)
Latest Headlines for CVS Health Corp (NYSE:CVS)
DateHeadline logoBetter Buy: CVS Health Corporation vs. Walgreen Boots Alliance - May 27 at 2:28 PM logo Brokerages Expect CVS Health Corp (CVS) Will Post Quarterly Sales of $45.37 Billion - May 27 at 8:44 AM logoCVS's Omnicare to pay $23 million to resolve U.S. kickback case - May 26 at 10:09 PM logoTax Reforms and Spending Cuts to Balance Trump’s Budget Plan - May 25 at 6:23 PM logoIs CVS Health's Dividend Safe? - May 25 at 6:23 PM logoCVS Health Corp (CVS) Raised to "Strong-Buy" at Vetr Inc. - May 25 at 12:38 AM logoPetition urges Laguna Beach planners to deny CVS’ application - May 24 at 12:39 PM logoCVS Health Corp (CVS) Lowered to "Buy" at Vetr Inc. - May 24 at 12:28 AM logoAttorney General Brnovich, Rep. Carter Join CVS Health to Announce Availability of Naloxone at All CVS Pharmacy Locations in Arizona - May 23 at 4:24 PM logoA Closer Look at CVS Health's Dividend Potential - May 23 at 4:24 PM logoETFs with exposure to CVS Health Corp. : May 19, 2017 - May 19 at 4:28 PM logoCVS Health Corp (CVS) Receives Average Recommendation of "Buy" from Brokerages - May 19 at 12:52 PM logoCVS Health Corp. :CVS-US: Earnings Analysis: Q1, 2017 By the Numbers : May 18, 2017 - May 18 at 10:49 AM logoCVS Health Corp (CVS) Lifted to Strong-Buy at Vetr Inc. - May 18 at 12:21 AM logoHow CVS CIO Stephen J. Gold Keeps Ahead of the Innovation Curve - May 17 at 11:20 AM logoWhy Your Pharmacy May Be Texting You - May 17 at 11:20 AM logoCVS Health Corp. breached its 50 day moving average in a Bearish Manner : CVS-US : May 17, 2017 - May 17 at 11:20 AM logoCVS's Omnicare to pay $8 million to settle U.S. probe - May 16 at 9:39 PM logoHealthcare Stocks on Investors' Radar -- CVS Health, Express Scripts, Aetna, and Cigna - PR Newswire (press release) - May 16 at 4:38 PM logoCVS Pharmacy Launches Long Live Skin Campaign to Increase Awareness Around Sun Safety and Skin Health - May 15 at 11:58 AM logoCVS Health, Walgreens: Key To Health Care Reform On Main Street, USA - May 15 at 11:58 AM logoCVS Health Corp (CVS) Short Interest Update - May 15 at 7:24 AM logoCharles Brandes Invests in Health Care in 1st Quarter - May 12 at 5:07 PM logoCVS Health To Present At The UBS Global Healthcare Conference - May 12 at 5:07 PM logoCVS Health (CVS) Shareholders Announce Former SEC Chairwoman, Mary Shapiro as New Director Following Board Elections - May 11 at 5:13 PM logoFY2017 EPS Estimates for CVS Health Corp Lifted by Analyst (CVS) - May 11 at 11:26 AM logoCVS Health Corporate Social Responsibility Activities Address Important National and Local Health Care Issues and Contribute to Economic Growth - May 10 at 4:46 PM logoCVS Health Stockholders Elect Former SEC Chairman Mary L. Schapiro as New Director at Annual Meeting - May 10 at 4:46 PM logoQ2 2017 EPS Estimates for CVS Health Corp Decreased by Analyst (CVS) - May 10 at 8:30 AM logoFca Corp Buys BLACKROCK INTERNATIONAL Blackrock Internation, CVS Health Corp, Halliburton Co, ... - May 9 at 4:34 PM logoWalgreens, Rite Aid Start The Clock For FTC To OK Merger - May 9 at 4:34 PM logoThe simple way MedStar just found to get patients to keep up with their meds - May 8 at 4:26 PM logoCVS Down on Weak Earnings, Pharmacy Services Remains Strong - May 8 at 9:34 AM logoCVS Health Corp to Post Q2 2017 Earnings of $1.32 Per Share, Leerink Swann Forecasts (CVS) - May 8 at 8:30 AM logoCVS: Overreaction To Earnings Gives Investors A Buying Opportunity - Seeking Alpha - May 5 at 4:49 PM logoEquities Analysts Offer Predictions for CVS Health Corp's Q3 2017 Earnings (CVS) - May 5 at 11:22 AM
News IconBRIEF-CVS Health reports Q1 adjusted earnings per share $1.17 - May 4 at 9:47 PM logoBrokers Set Expectations for CVS Health Corp's Q2 2017 Earnings (CVS) - May 4 at 9:19 AM logoQ2 2017 EPS Estimates for CVS Health Corp Reduced by Analyst (CVS) - May 4 at 9:18 AM logoCVS Health Reports First Quarter Results; Confirms 2017 EPS Guidance - PR Newswire (press release) - May 4 at 7:49 AM logoCVS Health Offering Hepatitis A Vaccine to Hawaii Residents Following Recall of Contaminated Fish - May 4 at 7:49 AM logoInvestors Purchase Large Volume of CVS Health Corp Call Options (CVS) - May 4 at 7:12 AM logoCovered Call reports for Coach, CVS Health Corp, The Kroger Co, NVIDIA and Sprint Corp include trade ideas that offer returns of 18% or more! - May 3 at 4:32 PM logoCVS profit falls on soft traffic to stores - May 3 at 9:00 AM logoDiversityInc® Recognizes CVS Health on List of "Top 50 Companies for Diversity" - May 3 at 9:00 AM logoCVS Health Corp. breached its 50 day moving average in a Bearish Manner : CVS-US : May 3, 2017 - May 3 at 9:00 AM logoEdited Transcript of CVS earnings conference call or presentation 2-May-17 12:30pm GMT - May 3 at 9:00 AM logoCVS Health Corp Sees Unusually High Options Volume (CVS) - May 3 at 7:04 AM logoSomewhat Favorable News Coverage Very Likely to Impact CVS Health Corp (CVS) Stock Price - May 2 at 7:56 PM logoCVS Profit Declines in First Quarter of ‘Rebuilding Year’ - May 2 at 7:20 PM



CVS Health Corp (CVS) Chart for Saturday, May, 27, 2017

This page was last updated on 5/27/2017 by Staff